{"id":"W2889677173","doi":"10.1200/jco.2018.36.15_suppl.9537","title":"Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Avelumab; Medicine; Merkel cell carcinoma; Expanded access; Internal medicine; Progressive disease; Merkel cell polyomavirus; Clinical trial; Oncology; Carcinoma; Chemotherapy; Nivolumab; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004662088,0.0002249537,0.0002637136,0.0001296401,0.0001919163,0.0004638013,0.0001552948,0.0002335354,0.002191726],"category_scores_gemma":[0.0004878116,0.00007672279,0.0003648968,0.0002278636,0.0001361582,0.0004332082,0.0003077222,0.0006683147,0.0006188063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003918098,"about_ca_system_score_gemma":0.000369995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004637539,"about_ca_topic_score_gemma":0.001327032,"domain_scores_codex":[0.9998807,0.0000496287,0.000008149008,0.00002374707,0.0000153138,0.00002254285],"domain_scores_gemma":[0.9997374,0.00004777694,0.0000464577,0.00001931175,0.00001775827,0.0001312351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01377205,0.004752647,0.05470373,0.0005504528,0.0004093849,0.002223122,0.0008259513,0.001731554,0.02691013,0.0003948597,0.01318376,0.8805423],"study_design_scores_gemma":[0.02991065,0.1852636,0.4835925,0.0007010645,0.001352184,0.04112175,0.0009982639,0.00596608,0.03128362,0.0008444074,0.2188731,0.00009273961],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740325,0.01401175,0.001691899,0.001009253,0.00009206311,0.0002939206,0.0005646254,0.00007143904,0.008232572],"genre_scores_gemma":[0.9846867,0.00758207,0.001719598,0.001270482,0.0001438214,0.0001107086,0.001446929,0.00004159056,0.002998129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002191726,"threshold_uncertainty_score":0.007332027,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1306409340776007,"score_gpt":0.4902485044401154,"score_spread":0.3596075703625146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}